Avalon Globocare Corp. (NASDAQ:AVCO) Forms a Colossal Partnership
Avalon GloboCare Corp. (NASDAQ:AVCO), a leading clinical-stage global developer of cell-based technologies and therapeutics, announced that they have established a strategic partnership with GE Healthcare. The partnership will accelerate Avalon's standardization, automation and bio-production for clinical-grade Chimeric Antigen Receptor (CAR)-T cells and other immune-effector cells for cellular immunotherapy, as well as exosomes/extracellular vesicles (EV) based regenerative therapeutics. The combination of expertise sets the stage for Avalon to be the leader in cellular medicines with the ability to execute on the...
View full press release